Effects of two administration routes of simvastatin on the maxillary bone loss in periodontitis rats associated with osteoporosis

Xinchen Xu,Hui Chen,Xi Zhang,Meihui Huang,Eryi Lu
DOI: https://doi.org/10.11752/j.kqcl.2015.02.05
2015-01-01
Abstract:ObjectiveTo compare the effects of local and oral administration of simvastatin (SIM) on maxillary alveolar bone loss in the animal model with periodontitis and osteoporosis.MethodsTwenty-four of 4-month-old female Sprague Dawley rats were randomly assigned to four groups: SHAM group, ovariectomy + ligature (OVX+LIG) group, OVX+LIG+Oral SIM group, OVX+LIG+Local SIM group. One month after OVX, ligatures were placed on the maxillaryfirst (M1) and second molars (M2) for 4 weeks on all rats except those in SHAM group, followed by simvastatin treatment for 8 weeks. The maxillae and serum were collected for further examination including micro-computed tomography, Van Gieson’s staining, and enzyme-linked immunosorbent assays (ELISA).ResultsCompared to OVX+LIG group, the distance between cemento-enamel junction and alveolar bone crest (CEJ-ABC) was decreased in OVX+LIG+Local SIM group, and bone mineral density (BMD) and bone volume fraction (BVF) in the maxillary of rats was increased, while in OVX+LIG+Oral SIM group, BMD, BVF and the level of osteocalcin were increased (OC), and the level of TRAP5b was decreased.Conclu-sionThe local and oral administration of simvastatin could reduce alveolar bone loss in the maxillary following ovariectomy (OVX) and ligature placement in rats, and the local simvastatin administration could promote bone formation in the alveolar bone crest.
What problem does this paper attempt to address?